Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease. [electronic resource]
Producer: 20180611Description: 818-824 p. digitalISSN:- 1437-7799
- Aged
- Aged, 80 and over
- Antiviral Agents -- adverse effects
- Carbamates
- Drug Therapy, Combination
- Female
- Genotype
- Glomerular Filtration Rate
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Imidazoles -- adverse effects
- Isoquinolines -- adverse effects
- Japan
- Kidney -- physiopathology
- Longitudinal Studies
- Male
- Pyrrolidines
- RNA, Viral -- blood
- Renal Insufficiency, Chronic -- complications
- Retrospective Studies
- Sulfonamides -- adverse effects
- Sustained Virologic Response
- Time Factors
- Treatment Outcome
- Valine -- analogs & derivatives
- Viral Load
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.